Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

18 May 2012 07:00

RNS Number : 6150D
Wilmington Group Plc
18 May 2012
 



 

18 May 2012

 

Wilmington Group plc

 

Interim Management Statement

 

Wilmington Group plc, the professional information and training group, today issues its interim management statement for the period from 1 January 2012 until the date of this announcement.

 

Trading Performance

 

Overall trading performance in the quarter ended 31 March 2012 and subsequently to the date of this statement has been in line with our expectations.

 

Revenues in the quarter to 31 March 2012 were 2% ahead of the corresponding period in the prior year, with Publishing & Information and Training & Events 2.4% ahead and 1.6% ahead respectively. Profit margins in both divisions made progress, particularly so in Training & Events, driven by the cost reductions that resulted from the changes implemented in the Autumn.

 

Cash flow during the period covered by this announcement has been strong with net debt at 30 April 2012 of £39.3m (April 2011: £40.4m).

 

Outlook

 

Our outlook for the full year remains unchanged with Adjusted EBITA1 showing improvement and Adjusted Profit before Tax2 being broadly in line with the prior year reflecting increased finance charges from the banking arrangements put in place in June 2011.

 

Most areas of our business are performing in line with our plans. The transition of our publishing business towards a fully digital business continues and with it the phasing out of the remaining print products. The actions we took in the first half of the financial year to implement changes to the legal training business are delivering benefits. We are mindful of the continuing difficult economic conditions, particularly in the UK and Europe, and are managing our cost base accordingly.

 

We remain committed to building a higher quality business which will deliver additional shareholder value in the years ahead.

 

 

1 Adjusted EBITA - Adjusted Profit before Tax and net finance costs

2 Adjusted Profit before Tax - profit before tax, amortisation of intangible assets, unwinding of the discount on the provisions for future purchase of non-controlling interests, unwinding of the discount on deferred consideration, share based payments and non-recurring items

 

-ends-

 

 

For further information, please contact:

 

Wilmington Group Plc

020 7422 6800

Charles Brady, Chief Executive

Basil Brookes, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne or Stephanie Badjonat

 

Notes to Editors

 

Wilmington Group plc is one of the UK's leading providers of information and training for professional business markets including accountancy and tax; banking; charities; financial compliance; healthcare; insurance; law and pensions. Capitalised at approximately £80 million, Wilmington floated on the London Stock Exchange in 1995.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGURUAUPPGQM
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.